Biotechnology
Company Overview of Helix Therapeutics, Inc.
Company Overview
Helix Therapeutics, Inc. develops deoxyribonucleic acid (DNA) based therapeutics. It develops novel sequence-specific gene-targeting reagents for the treatment of HIV/AIDS and common genetic diseases, such as sickle cell anemia, thalassemia, and cystic fibrosis. The company was founded in 2006 and is based in New Haven, Connecticut.
150 Munson Street
25 Science Park
New Haven, CT 06511
United States
Founded in 2006
Phone:
203-772-2888
Key Executives for Helix Therapeutics, Inc.
Similar Private Companies By Industry
| Company Name | Region |
| CR, LLC | United States |
| Reliable Biopharmaceutical Corporation | United States |
| Protagenic Therapeutics Inc. | United States |
| Organon Pharmaceuticals USA, Inc. | United States |
| New England Research Institutes, Inc. | United States |
Recent Private Companies Transactions
| Type Date |
Target | |
| No transactions available in the past 12 months. | ||
Most Searched Private Companies
| Company Name | Geographic Region |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| NYC2012, Inc. | United States |
| Rush University | United States |
| Citizens Budget Commission | United States |
Post a JobJobs
- Boston, MA | PwCPosted: Aug 28
- Kennebunk, ME | CorningPosted: May 24
- Madison, WI | Madison Area Technical CollegePosted: May 23
- San Francisco, CA | Confidential Biotechnology CompanyPosted: May 13
Sponsored Financial Commentaries
Sponsored Links
To contact Helix Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
